Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on ...

U.S. Food and Drug Administration accepts sNDA for filing with priority review; sets PDUFA goal date of December 20, 2025 -- – European Medicines Agency accepts and validates submission for Type II ...

Climate change-driven weather disasters like hurricanes, wildfires and floods pose an immediate threat to the U.S. drug ...

Notably, there was a trend of European pharmaceutical giants acquiring US-based biotechnology firms, such as GSK's (NYSE:GSK) acquisition of Boston Pharmaceuticals’ subsidiary, BP Asset IX, to ...

We are thrilled to welcome Albert to Imbria at such a critical time for the company,” said Alvin Shih, MD, Imbria's Chief Executive Officer.“His deep expertise in cardiovascular medicine, proven track ...

BOSTON (AP) — BOSTON (AP) — X4 Pharmaceuticals, Inc. (XFOR) on Friday reported a loss of $25.7 million in its second quarter. On a per-share basis, the Boston-based company said it had a loss of $3.47 ...

The RMR Group secured a $1 billion refinancing for Vertex Pharmaceuticals' Boston Seaport headquarters, a five-year, interest ...

A joint venture led by locally based REIT Diversified Healthcare Trust (NASDAQ: DHC) has received $1 billion for the refinancing of the Vertex Pharmaceuticals headquarters facility in Boston. A ...

Boston's new commuter ferry connects Seaport District and North Station, funded by the city and private sector.

Bold vision for ancient Chinese garden city could see it evolve into a world-leading biotechnology hub, hosting 10,000 ...